[Skip to Content]
[Skip to Content Landing]

Precision Medicine for Your Practice: Genomic Testing in Pediatric Neurology

Learning Objectives
1. Identify scenarios in which there is further value added by molecular diagnosis
2. Evaluate the appropriateness of different genetic/genomic tests for clinical context
3. Evaluate when consulting a genetic expert can be helpful
0.5 Credit CME

Pediatric neurology providers and patients have more options than ever before for genetic testing. Evidence is growing for the utility of genetic testing for a range of conditions for the purpose of diagnosis and optimizing treatment. While genetic testing can be a powerful tool in certain situations, not all genetic testing is the same. Broader tests assess more genes and increase the possibility of a diagnosis, but also confer specific benefits, limitations, and challenges in results interpretation and counseling.

Precision Medicine for Your Practice is a series of short (20-30 min), online modules covering specific topics in genomics and precision medicine. In this module, Genetic Testing in Pediatric Neurology, participants will learn the benefits and limitations of genetic testing for pediatric neurological conditions. This online module will include five parts: overview information via an animated video; practice cases to facilitate learning-by-doing; and "dig deeper," logistics, and additional resources for those who are interested in more detail.

Sign in to take quiz and track your certificates

To help improve the quality of its educational content and meet applicable education accreditation requirements, the content provider will receive record of your participation and responses to this activity.

Clinical Education from The Jackson Laboratory

Clinical Education from The Jackson Laboratory empowers physicians and healthcare professionals to integrate genomics into their clinical practice. Learn more

Module not playing? Click here

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to:

1 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program;

1 Self-Assessment points in the American Board of Otolaryngology – Head and Neck Surgery’s (ABOHNS) Continuing Certification program;

1 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program; and

1 Lifelong Learning points in the American Board of Pathology’s (ABPath) Continuing Certification program;

It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting MOC credit.

Activity Information

Credit Designation Statement: The American Medical Association designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CME Disclosure Statement: Unless noted, all individuals in control of content reported no relevant financial relationships.

If applicable, all relevant financial relationships have been mitigated.

Credit Renewal Date: September 8, 2022

Target Audience

This activity is designed to meet the educational needs of practicing physicians who work with children with neurologic conditions.

Accreditation

The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Hardware/Software Requirements

Audio speakers or headphones

Screen resolution of 800X600 or higher

Adobe Reader 5.0 or higher

Check the supported browsers.

Should you have technical questions or questions regarding the content of the activity, please email Clinical and Continuing Education at the Jackson Laboratory.

Multimedia Contributors

• Emily Edelman, MS, CGC, Director, Clinical Education, The Jackson Laboratory

• Therese Ingram, MA, Associate Director and Senior Instructional Designer/Technologist, Clinical Education, The Jackson Laboratory

• Laura Nicholson, MD, PhD, Director of Research, Graduate Medical Education (GME), Scripps Health

• Kate Reed, MPH, ScM, CGC, Director, Precision Oncology Education, Clinical Education, The Jackson Laboratory

• Linda Steinmark, MS, CGC, Project Manager, Clinical Education, The Jackson Laboratory

Disclaimer

All information in Precision Medicine for Your Practice is provided for educational purposes only. This information is not a substitute for clinical guidance or the consultation of a medical professional. Always seek the advice of a qualified health professional with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read in Precision Medicine for Your Practice. Reliance on any information in Precision Medicine for Your Practice is solely at your own risk. The Jackson Laboratory does not endorse or recommend any specific procedures, tests, products, services, health professionals or other information that may be found in Precision Medicine for Your Practice.

References:
1.
Baker  E, Jeste  S.  Diagnosis and Management of Autism Spectrum Disorder in the Era of Genomics Rare Disorders Can Pave the Way for Targeted Treatments.  Pediatr Clin North Am. 2015;62:607–618.Google Scholar
2.
Bello  L, Pegoraro  E.  Genetic diagnosis as a tool for personalized treatment of Duchenne muscular dystrophy.  Acta Myol. 2016;35(3):122–127.Google Scholar
3.
Bioethics Committee, Committee on Genetics, American College of Medical Genetics and Genomics Social, Ethical, and Legal Committee (2013).  Ethical and Policy Issues in Genetic Testing and Screening of Children.  Pediatrics. 2013;131(3):620–622.Google Scholar
4.
Bird TD.  Approaches to the Patient with Neurogenetic Disease.  Clin Lab Med. 2010;30:785–793.Google Scholar
5.
Bush LW, Bartoshesky LE, David KL, Wilfond B, Williams JL, Holm IA; ACMG SELI committee.  Pediatric clinical exome/genome sequencing and the engagement process: encouraging active conversation with the older child and adolescent: points to consider-a statement of the American College of Medical Genetics and Genomics (ACMG).  Genet Med. 2018 Jul;20(7):692–694.Google Scholar
6.
Deignan JL, Chung WK, Kearney HM, Monaghan KG, Rehder CW, Chao EC; ACMG Laboratory Quality Assurance Committee.  Points to consider in the reevaluation and reanalysis of genomic test results: a statement of the American College of Medical Genetics and Genomics (ACMG).  Genet Med. 2019 Jun;21(6):1267–1270.Google Scholar
7.
Demarest ST, Brooks-Kayal A.  From molecules to medicines: the dawn of targeted therapies for genetic epilepsies.  Nat Rev Neurol. 2018;14(12):735–745.Google Scholar
8.
Dowling JJ, D Gonorazky H, Cohn RD, Campbell C.  Treating pediatric neuromuscular disorders: The future is now.  Am J Med Genet A. 2018;176(4):804–841.Google Scholar
9.
Finucane B, Abrams L, Cronister A, Archibald AD, Bennett RL, McConkie-Rosell A.  Genetic Counseling and Testing for FMR1 Gene Mutations: Practice Guidelines of the National Society of Genetic Counselors.  J Genet Couns. 2012;21(6):752–760.Google Scholar
10.
Fogel BL.  Genetic and genomic testing for neurologic disease in clinical practice.  Handb Clin Neurol. 2018;147:11–22.Google Scholar
11.
Fogel BL, Saty Satya-Murti, Cohen BH.  Clinical exome sequencing in neurologic disease.  Neurol Clin Pr. 2016;6:164–176.Google Scholar
12.
Han JY, Lee IG.  Genetic tests by next-generation sequencing in children with developmental delay and/or intellectual disability.  Clin Exp Pediatr. 2020 Jun;63(6):195–202.Google Scholar
13.
Huang Y, Yu S, Wu Z TB.  Genetics of hereditary neurological disorders in children.  Transl Pediatr. 2014;3(2):108–119.Google Scholar
14.
Hyman SL, Levy SE, Myers SM..  Executive Summary: Identification, Evaluation, and Management of Children With Autism Spectrum Disorder  Pediatrics. 2020 Jan;145(1):e20193448.Google Scholar
15.
Kang PB.  Ethical issues in neurogenetic disorders.  Ethical Leg Issues Neurol. 2013;118:265–276.Google Scholar
16.
Kaufmann WE.  Neurogenetics in Child Neurology: Redefining a Discipline in the Twenty-first Century.  Curr Neurol Neurosci Rep. 2016;16:103.Google Scholar
17.
Kiely B, Vettam S, Adesman A.  Utilization of genetic testing among children with developmental disabilities in the United States.  Appl Clin Genet. 2016;9:93–100.Google Scholar
18.
Malinowski J, Miller DT, Demmer L, Gannon J, Pereira EM, Schroeder MC, Scheuner MT, Tsai AC, Hickey SE, Shen J; ACMG Professional Practice and Guidelines Committee.  Systematic evidence-based review: outcomes from exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability.  Genet Med. 2020 Jun;22(6):986–1004.Google Scholar
19.
Manickam K, McClain MR, Demmer LA, Biswas S, Kearney HM, Malinowski J, Massingham LJ, Miller D, Yu TW, Hisama FM; ACMG Board of Directors.  Exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability: an evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG).  Genet Med. 2021 Nov;23(11):2029–2037.Google Scholar
20.
Manning M, Hudgins L; American College of Medical Genetics and Genomics (ACMG) Professional Practice and Guidelines Committee.  Addendum: Array-based technology and recommendations for utilization in medical genetics practice for detection of chromosomal abnormalities (ACMG).  Genet Med. 2020 Dec;22(12):2126.Google Scholar
21.
Miller DT, Lee K, Chung WK, Gordon AS, Herman GE, Klein TE, Stewart DR, Amendola LM, Adelman K, Bale SJ, Gollob MH, Harrison SM, Hershberger RE, McKelvey K, Richards CS, Vlangos CN, Watson MS, Martin CL; ACMG Secondary Findings Working Group.  ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG).  Genet Med. 2021 Aug;23(8):1381–1390.Google Scholar
22.
Miller DT, Lee K, Gordon AS, Amendola LM, Adelman K, Bale SJ, Chung WK, Gollob MH, Harrison SM, Herman GE, Hershberger RE, Klein TE, McKelvey K, Richards CS, Vlangos CN, Stewart DR, Watson MS, Martin CL; ACMG Secondary Findings Working Group.  Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2021 update: a policy statement of the American College of Medical Genetics and Genomics (ACMG).  Genet Med. 2021 Aug;23(8):1391–1398.Google Scholar
23.
Narayanan V.  Genetics and Child Neurology: What Every Trainee/Resident Should Know.  Semin Pediatr Neurol. 2011;18:81–84.Google Scholar
24.
Neubauer BA, Lemke JR.  From Genetics to Genomics: A Short Introduction for Pediatric Neurologists.  Neuropediatrics. 2016;47:5–11.Google Scholar
25.
Ream MA, Patel AD.  Obtaining genetic testing in pediatric epilepsy.  Epilepsia. 2015;56(10):1505–1514.Google Scholar
26.
Savatt JM, Myers SM.  Genetic Testing in Neurodevelopmental Disorders.  Front Pediatr. 2021 Feb19 ;9:526779.Google Scholar
27.
Silveira-Moriyama L, Paciorkowski AR.  Genetic Diagnostics for Neurologists.  Contin Lifelong Learn Neurol. 2018;24(1):18–36.Google Scholar
28.
Sisodiya SM.  Genetic screening and diagnosis in epilepsy?  Curr Opin Neurol. 2015;28(2):136–142.Google Scholar
29.
Spector E, Behlmann A, Kronquist K, Rose NC, Lyon E, Reddi HV; ACMG Laboratory Quality Assurance Committee.  Laboratory testing for fragile X, 2021 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG).  Genet Med. 2021 May;23(5):799–812.Google Scholar
30.
Vento JM.  Family History: A Guide for Neurologists in the Age of Genomic Medicine.  Semin Pediatr Neurol. 2012;19:160–166.Google Scholar
31.
Waggoner D, Wain KE, Dubuc AM, Conlin L, Hickey SE, Lamb AN, Martin CL, Morton CC, Rasmussen K, Schuette JL, Schwartz S, Miller DT; ACMG Professional Practice and Guidelines Committee.  Yield of additional genetic testing after chromosomal microarray for diagnosis of neurodevelopmental disability and congenital anomalies: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG).  Genet Med. 2018 Oct;20(10):1105–1113.Google Scholar
Close
Close
Close
Close

Name Your Search

Save Search
Close
Close

Lookup An Activity

or

My Saved Searches

You currently have no searches saved.

Close

My Saved Courses

You currently have no courses saved.

Close